Insider: Kassberg Thomas Richard CBO & EVP - Ultragenyx Pharmaceutical Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 265,238 | 0 | 265,238 |
| Value | $7,378,921.16 | $0.00 | $7,378,921.16 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/03/2025 | DDS | 6,028 | Direct | COM | $42.10 | $253,778.80 | 265,238 |
| 03/11/2024 | DDS | 11,509 | Direct | COM | $49.93 | $574,644.37 | 252,823 |
| 03/01/2024 | DDS | 1,011 | Direct | COM | $53.76 | $54,351.36 | 264,332 |
| 10/23/2023 | DDS | 39,878 | Direct | COM | $32.78 | $1,307,200.84 | 246,860 |
| 03/01/2023 | DDS | 1,968 | Direct | COM | $45.27 | $89,091.36 | 250,254 |
| 03/11/2022 | DDS | 10,281 | Direct | COM | $67.01 | $688,929.81 | 227,559 |
| 03/01/2022 | DDS | 2,374 | Direct | COM | $66.62 | $158,155.88 | 213,840 |
| 10/14/2021 | DDS | 286 | Direct | COM | $81.14 | $23,206.04 | 216,266 |
| 05/06/2021 | DDS | 363 | Direct | COM | $113.69 | $41,269.47 | 106,818 |
| 03/01/2021 | DDS | 4,572 | Direct | COM | $138.17 | $631,713.24 | 107,181 |
| 10/14/2020 | DDS | 262 | Direct | COM | $87.98 | $23,050.76 | 101,478 |
| 08/12/2015 | DDS | 3,334 | Direct | COM | $109.70 | $365,739.80 | 70,204 |
| 07/08/2015 | DDS | 3,334 | Direct | COM | $102.12 | $340,468.08 | 73,538 |
| 06/10/2015 | DDS | 3,334 | Direct | COM | $88.19 | $294,025.46 | 76,872 |
| 05/13/2015 | DDS | 3,334 | Direct | COM | $72.04 | $240,181.36 | 75,806 |
| 04/08/2015 | DDS | 3,333 | Direct | COM | $58.02 | $193,380.66 | 79,140 |
| 03/11/2015 | DDS | 3,333 | Direct | COM | $56.30 | $187,647.90 | 82,473 |
| 02/11/2015 | DDS | 3,333 | Direct | COM | $54.31 | $181,020.90 | 85,806 |
| 01/14/2015 | DDS | 3,333 | Direct | COM | $51.51 | $171,682.83 | 89,139 |
| 12/10/2014 | DDS | 3,333 | Direct | COM | $40.22 | $134,053.26 | 92,472 |
| 11/12/2014 | DDS | 3,333 | Direct | COM | $41.85 | $139,486.05 | 95,805 |
| 10/08/2014 | DDS | 3,333 | Direct | COM | $53.26 | $177,515.58 | 99,138 |
| 09/10/2014 | DDS | 3,333 | Direct | COM | $54.82 | $182,715.06 | 102,471 |
| 09/03/2014 | DDS | 10,000 | Direct | COM | $55.00 | $550,000.00 | 105,804 |
| 09/02/2014 | DDS | 10,000 | Direct | COM | $52.82 | $528,200.00 | 115,804 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research